426 related articles for article (PubMed ID: 21906903)
1. A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease.
Mwipatayi BP; Thomas S; Wong J; Temple SE; Vijayan V; Jackson M; Burrows SA;
J Vasc Surg; 2011 Dec; 54(6):1561-70. PubMed ID: 21906903
[TBL] [Abstract][Full Text] [Related]
2. Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease.
Mwipatayi BP; Sharma S; Daneshmand A; Thomas SD; Vijayan V; Altaf N; Garbowski M; Jackson M;
J Vasc Surg; 2016 Jul; 64(1):83-94.e1. PubMed ID: 27131926
[TBL] [Abstract][Full Text] [Related]
3. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of covered versus bare-metal balloon-expandable stents for aortoiliac occlusive disease.
Humphries MD; Armstrong E; Laird J; Paz J; Pevec W
J Vasc Surg; 2014 Aug; 60(2):337-43. PubMed ID: 24725909
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions.
Piazza M; Squizzato F; Spolverato G; Milan L; Bonvini S; Menegolo M; Grego F; Antonello M
J Vasc Surg; 2015 Nov; 62(5):1210-8.e1. PubMed ID: 26254822
[TBL] [Abstract][Full Text] [Related]
6. Covered versus bare metal kissing stents for reconstruction of the aortic bifurcation in the ILIACS registry.
Squizzato F; Piazza M; Pulli R; Fargion A; Piffaretti G; Pratesi C; Grego F; Antonello M;
J Vasc Surg; 2021 Jun; 73(6):1980-1990.e4. PubMed ID: 33253875
[TBL] [Abstract][Full Text] [Related]
7. Balloon-expandable covered stent therapy of complex endovascular pathology.
Giles H; Lesar C; Erdoes L; Sprouse R; Myers S
Ann Vasc Surg; 2008 Nov; 22(6):762-8. PubMed ID: 18922676
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II.
Ichihashi S; Higashiura W; Itoh H; Sakaguchi S; Nishimine K; Kichikawa K
J Vasc Surg; 2011 Apr; 53(4):992-9. PubMed ID: 21215582
[TBL] [Abstract][Full Text] [Related]
9. Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.
Dosluoglu HH; Cherr GS; Lall P; Harris LM; Dryjski ML
J Vasc Surg; 2008 Nov; 48(5):1166-74. PubMed ID: 18692357
[TBL] [Abstract][Full Text] [Related]
10. Iliac artery stenting combined with open femoral endarterectomy is as effective as open surgical reconstruction for severe iliac and common femoral occlusive disease.
Piazza M; Ricotta JJ; Bower TC; Kalra M; Duncan AA; Cha S; Gloviczki P
J Vasc Surg; 2011 Aug; 54(2):402-11. PubMed ID: 21531527
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of covered expandable stents for the treatment of TASC D aorto-iliac occlusive lesions.
Tewksbury R; Taumoepeau L; Cartmill A; Butcher A; Cohen T
Vascular; 2015 Dec; 23(6):630-6. PubMed ID: 25819513
[TBL] [Abstract][Full Text] [Related]
12. Midterm outcome of balloon-expandable polytetrafluoroethylene-covered stents in the treatment of iliac artery chronic occlusive disease.
Grimme FA; Spithoven JH; Zeebregts CJ; Scharn DM; Reijnen MM
J Endovasc Ther; 2012 Dec; 19(6):797-804. PubMed ID: 23210879
[TBL] [Abstract][Full Text] [Related]
13. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial.
Rastan A; Tepe G; Krankenberg H; Zahorsky R; Beschorner U; Noory E; Sixt S; Schwarz T; Brechtel K; Böhme C; Neumann FJ; Zeller T
Eur Heart J; 2011 Sep; 32(18):2274-81. PubMed ID: 21622669
[TBL] [Abstract][Full Text] [Related]
15. Stent Protrusion >20 mm Into the Aorta: A New Predictor for Restenosis After Kissing Stent Reconstruction of the Aortoiliac Bifurcation.
Vértes M; Juhász IZ; Nguyen TD; Veres DS; Hüttl A; Nemes B; Hüttl K; Dósa E
J Endovasc Ther; 2018 Oct; 25(5):632-639. PubMed ID: 30122138
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of three polytetrafluoroethylene stent-grafts in a model of neointimal hyperplasia.
Dolmatch B; Dong YH; Heeter Z
J Vasc Interv Radiol; 2007 Apr; 18(4):527-34. PubMed ID: 17446544
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous angioplasty and stenting of the superficial femoral artery.
Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
[TBL] [Abstract][Full Text] [Related]
18. 24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D Lesions.
de Donato G; Bosiers M; Setacci F; Deloose K; Galzerano G; Verbist J; Peeters P; Setacci C
Ann Vasc Surg; 2015; 29(4):738-50. PubMed ID: 25733220
[TBL] [Abstract][Full Text] [Related]
19. Increasing efficacy of endovascular recanalization with covered stent graft for TransAtlantic Inter-Society Consensus II D aortoiliac complex occlusion.
Psacharopulo D; Ferrero E; Ferri M; Viazzo A; Singh Bahia S; Trucco A; Ricceri F; Nessi F
J Vasc Surg; 2015 Nov; 62(5):1219-26. PubMed ID: 26391459
[TBL] [Abstract][Full Text] [Related]
20. Covered stents for aortoiliac reconstruction of chronic occlusive lesions.
Grimme FA; Goverde PA; Van Oostayen JA; Zeebregts CJ; Reijnen MM
J Cardiovasc Surg (Torino); 2012 Jun; 53(3):279-89. PubMed ID: 22695260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
